Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Saved in:
| Title: | Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. |
|---|---|
| Authors: | Rovin BH; Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Teng YKO; Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands., Ginzler EM; Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA., Arriens C; Department of Arthritis & Clinical Immunology, Rheumatology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Caster DJ; Department of Medicine, Division of Nephrology and Hypertension, University of Louisville School of Medicine, Louisville, KY, USA., Romero-Diaz J; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico., Gibson K; Department of Medicine, UNC Kidney Center, Chapel Hill, NC, United States., Kaplan J; Department of Medicine, Rutgers University, Newark, NJ, USA., Lisk L; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada., Navarra S; University of Santo Tomas, Manila and St Luke's Medical Center, Quezon City, Philippines., Parikh SV; Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Randhawa S; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada., Solomons N; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada., Huizinga RB; Research, Aurinia Pharmaceuticals, Victoria, BC, Canada. Electronic address: rhuizinga@auriniapharma.com. |
| Source: | Lancet (London, England) [Lancet] 2021 May 29; Vol. 397 (10289), pp. 2070-2080. Date of Electronic Publication: 2021 May 07. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33971155 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rovin+BH%22">Rovin BH</searchLink>; Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Teng+YKO%22">Teng YKO</searchLink>; Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ginzler+EM%22">Ginzler EM</searchLink>; Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.<br /><searchLink fieldCode="AU" term="%22Arriens+C%22">Arriens C</searchLink>; Department of Arthritis & Clinical Immunology, Rheumatology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Caster+DJ%22">Caster DJ</searchLink>; Department of Medicine, Division of Nephrology and Hypertension, University of Louisville School of Medicine, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Romero-Diaz+J%22">Romero-Diaz J</searchLink>; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Gibson+K%22">Gibson K</searchLink>; Department of Medicine, UNC Kidney Center, Chapel Hill, NC, United States.<br /><searchLink fieldCode="AU" term="%22Kaplan+J%22">Kaplan J</searchLink>; Department of Medicine, Rutgers University, Newark, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lisk+L%22">Lisk L</searchLink>; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Navarra+S%22">Navarra S</searchLink>; University of Santo Tomas, Manila and St Luke's Medical Center, Quezon City, Philippines.<br /><searchLink fieldCode="AU" term="%22Parikh+SV%22">Parikh SV</searchLink>; Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Randhawa+S%22">Randhawa S</searchLink>; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Solomons+N%22">Solomons N</searchLink>; Clinical Development, Aurinia Pharmaceuticals, Victoria, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Huizinga+RB%22">Huizinga RB</searchLink>; Research, Aurinia Pharmaceuticals, Victoria, BC, Canada. Electronic address: rhuizinga@auriniapharma.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2021 May 29; Vol. 397 (10289), pp. 2070-2080. <i>Date of Electronic Publication: </i>2021 May 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33971155 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(21)00578-X Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2070 Titles: – TitleFull: Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rovin BH – PersonEntity: Name: NameFull: Teng YKO – PersonEntity: Name: NameFull: Ginzler EM – PersonEntity: Name: NameFull: Arriens C – PersonEntity: Name: NameFull: Caster DJ – PersonEntity: Name: NameFull: Romero-Diaz J – PersonEntity: Name: NameFull: Gibson K – PersonEntity: Name: NameFull: Kaplan J – PersonEntity: Name: NameFull: Lisk L – PersonEntity: Name: NameFull: Navarra S – PersonEntity: Name: NameFull: Parikh SV – PersonEntity: Name: NameFull: Randhawa S – PersonEntity: Name: NameFull: Solomons N – PersonEntity: Name: NameFull: Huizinga RB IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2021 May 29 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 397 – Type: issue Value: 10289 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |
